Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


Free Access

Monocytes and Macrophages Regulate Immunity through Dynamic Networks of Survival and Cell Death

Parihar A.c · Eubank T.D.a · Doseff A.I.a, b

Author affiliations

aDepartment of Internal Medicine, Division of Pulmonary and Critical Care, Heart and Lung Research Institute, and bDepartment of Molecular Genetics, The Ohio State University, Columbus, Ohio, USA; cDepartment of Biological Sciences, GDC College, Vikram University, Ujjain, India

Corresponding Author

Dr. Andrea I. Doseff

Heart and Lung Research Institute, The Ohio State University

473 West 12th Ave.

Columbus, OH 43220 (USA)

Tel. +1 614 292 9507, Fax +1 614 293 4799, E-Mail doseff.1@osu.edu

Related Articles for ""

J Innate Immun 2010;2:204–215

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Monocytes and macrophages are central cells of the innate immune system, responsible for defending against diverse pathogens. While they originate from a common myeloid precursor and share functions in innate immunity, each has a very distinct life span finely tuned by the apoptotic caspases. Normally, circulating monocytes are short-lived and undergo spontaneous apoptosis on a daily basis. Macrophages, however, have a longer life span. In chronic inflammatory diseases and, as recently recognized, in the tumor microenvironment, the inhibition of the apoptotic program promotes monocyte survival contributing to the accumulation of macrophages and the persistence of an inflammatory milieu. A complex network of differentiation factors and inflammatory stimuli determine monocyte/macrophage life span by blocking the apoptotic pathway and activating a myriad of survival pathways. Our understanding of apoptosis has flourished over the last decade, and its relevance in the regulation of the immune system is now indisputable. Nevertheless, how the complicated networks of survival and apoptotic regulators are integrated to determine cellular life span remains elusive. This review summarizes the contribution of the caspases and their regulators in monocyte/macrophage cell fate and discusses how these molecules orchestrate the initiation, maintenance, and resolution of inflammation. More provocatively, we discuss possible strategies to control inflammation by manipulating leukocyte life span.

© 2010 S. Karger AG, Basel


  1. Auffray C, Sieweke MH, Geissmann F: Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009;27:669–692.
  2. Fahy RJ, Doseff AI, Wewers MD: Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent pathway that is blocked by endotoxin and is independent of caspase-1. J Immunol 1999;163:1755–1762.
  3. Wiktor-Jedrzejczak W, Gordon S: Cytokine regulation of the macrophage (M phi) system studied using the colony stimulating factor-1-deficient op/op mouse. Physiol Rev 1996;76:927–947.
  4. Voss OH, Batra S, Kolattukudy SJ, Gonzalez-Mejia ME, Smith JB, Doseff AI: Binding of caspase-3 prodomain to heat shock protein 27 regulates monocyte apoptosis by inhibiting caspase-3 proteolytic activation. J Biol Chem 2007;282:25088–25099.
  5. Goyal A, Wang Y, Graham MM, Doseff AI, Bhatt NY, Marsh CB: Monocyte survival factors induce AKT activation and suppress caspase-3. Am J Respir Cell Mol Biol 2002;26:224–230.
  6. Savill J, Fadok V: Corpse clearance defines the meaning of cell death. Nature 2000;407:784–788.
  7. Linker R, Gold R, Luhder F: Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. Crit Rev Immunol 2009;29:43–68.
  8. Gonzalez-Mejia E, Doseff AI: Regulation of monocytes and macrophages cell fate. Front Biosci 2009;14:2413–2431.
  9. Grage-Griebenow E, Flad HD, Ernst M: Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 2001;69:11–20.
  10. Skrzeczynska-Moncznik J, Bzowska M, Loseke S, Grage-Griebenow E, Zembala M, Pryjma J: Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol 2008;67:152–159.
  11. Ziegler-Heitbrock L: The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007;81:584–592.
  12. Geissmann F, Jung S, Littman DR: Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003;19:71–82.
  13. Faure S, Meyer L, Costagliola D, Vaneensberghe C, Genin E, Autran B, Delfraissy JF, McDermott DH, Murphy PM, Debre P, Theodorou I, Combadiere C: Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 2000;287:2274–2277.
  14. Gordon S, Taylor PR: Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953–964.
  15. Ingersoll MA, Spanbroek R, Lottaz C, Gautier EL, Frankenberger M, Hoffmann R, Lang R, Haniffa M, Collin M, Tacke F, Habenicht AJ, Ziegler-Heitbrock L, Randolph GJ: Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 2010;115:e10–e19.
  16. Aschoff L: Das reticulo-emdotheliale system. Ergeb Inn Med Kinderheilkd 1924;26:1–118.
  17. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, Maher DW, Cebon J, Sinickas V, Dunn AR: Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994;91:5592–5596.
  18. Begg SK, Radley JM, Pollard JW, Chisholm OT, Stanley ER, Bertoncello I: Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med 1993;177:237–242.
  19. van Furth R, Cohm ZA: The origin and kinetics of mononuclear phagocytes. J Exp Med 1968;128:415–435.
  20. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S: Macrophage receptors and immune recognition. Annu Rev Immunol 2005;23:901–944.
  21. Kohro T, Tanaka T, Murakami T, Wada Y, Aburatani H, Hamakubo T, Kodama T: A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. J Atheroscler Thromb 2004;11:88–97.
  22. Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow. Lancet 2001;357:539–545.
  23. Sica A, Bronte V: Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007;117:1155–1166.
  24. Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C, Markowitz D, Wu W, Liu C, Reisfeld RA, Xiang R: Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 2006;116:2132–2141.
  25. Eubank TD, Roberts RD, Khan M, Curry JM, Nuovo GJ, Kuppusamy P, Marsh CB: Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Res 2009;69:2133–2140.
  26. Eubank TD, Roberts R, Galloway M, Wang Y, Cohn DE, Marsh CB: GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice. Immunity 2004;21:831–842.
  27. De Palma M, Murdoch C, Venneri MA, Naldini L, Lewis CE: Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol 2007;28:519–524.
  28. Waldburger JM, Suter T, Fontana A, Acha-Orbea H, Reith W: Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J Exp Med 2001;194:393–406.
  29. Akira S, Takeda K, Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675–680.
  30. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, Elbim C, Hitchcock R, Lammas D, Davies J, Al-Ghonaium A, Al-Rayes H, Al-Jumaah A, Al-Hajjar S, Al-Moshen IZ, Frayha HH, Rucker R, Hawn TR, Aderem A, Tufenkeji H, Haraguchi S, Day NK, Good RA, Gugerot-Pocidalo MA, Ozinsky A, Casanova JL: Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003;299:2076–2079.
  31. Akira S, Takeda K: Toll-like receptor signalling. Nat Immunol 2004;4:499–511.
  32. Reuter S, Lang D: Life span of monocytes and platelets: importance of interactions. Front Biosci 2009;14:2432–2447.
  33. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos CA: Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004;11:161–167.
  34. Gaur U, Aggarwal BB: Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003;66:1403–1408.
  35. Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, Guttdrige DC, Grotewold E, Doseff AI: Apigenin blocks lipopolysaccharide-induced lethality in vivo and pro-inflammatory cytokines expression by inactivating NF-ĸB through the suppression of p65 phosphorylation. J Immunol 2007;179:7121–7127.
  36. Doseff AI: Apoptosis: the sculptor of development. Stem Cells Developm 2004;13:473–483.
  37. Fahy RJ, Exline MC, Gavrilin MA, Bhatt NY, Besecker BY, Sarkar A, Hollyfield JL, Duncan MD, Nagaraja HN, Knatz NL, Hall M, Wewers MD: Inflammasome mRNA expression in human monocytes during early septic shock. Am J Respir Crit Care Med 2008;177:983–988.
  38. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 1998;281:1305–1308.
  39. Krammer PH: CD95 (APO-1/Fas)-mediated apoptosis: live and let die. Ad Immunol 1999;71:163–209.
  40. Nagata S: Fas ligand-induced apoptosis. Annu Rev Genet 1999;33:29–55.
  41. Parihar MS, Nazarewicz RR, Kincaid E, Bringold U, Ghafourifar P: Association of mitochondrial nitric oxide synthase activity with respiratory chain complex I. Biochem Biophys Res Commun 2008;366:23–28.
  42. Perez-Cruz I, Carcamo JM, Golde DW: Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells. Blood 2003;102:336–343.
  43. Malavez Y, Gonzalez-Mejia ME, Doseff AI: PKCδ. Atlas Genet Cytogenet Oncol Haematol. March 2008 http://AtlasGeneticsOncology.org/Genes/PRKCDID42901ch3p21.html (accessed March, 2010).
  44. Voss OH, Kim S, Wewers MD, Doseff AI: Regulation of monocyte apoptosis by the protein kinase C delta-dependent phosphorylation of caspase-3. J Biol Chem 2005;280:17371–17379.
  45. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC: Regulation of cell death protease caspase-9 by phosphorylation. Science 1998;282:1318–1321.
  46. Kelley TW, Graham MM, Doseff AI, Pomerantz RW, Lau SM, Ostrowski MC, Franke TF, Marsh CB: Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B. J Biol Chem 1999;274:26393–26398.
  47. Chang L, Karin M: Mammalian MAP kinase signalling cascades. Nature 2001;410:37–40.
  48. Erwig LP, Henson PM: Clearance of apoptotic cells by phagocytes. Cell Death Differ 2008;15:243–250.
  49. Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S, Xu Y, Autenrieth IB, Schulze-Osthoff K, Belka C, Stuhler G, Wesselborg S: Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 2003;113:717–730.
  50. Dayyani F, Belge KU, Frankenberger M, Mack M, Berki T, Ziegler-Heitbrock L: Mechanism of glucocorticoid-induced depletion of human CD14+CD16+ monocytes. J Leukoc Biol 2003;74:33–39.

Article / Publication Details

First-Page Preview
Abstract of Review

Received: December 21, 2009
Accepted: February 10, 2010
Published online: March 16, 2010
Issue release date: April 2010

Number of Print Pages: 12
Number of Figures: 1
Number of Tables: 1

ISSN: 1662-811X (Print)
eISSN: 1662-8128 (Online)

For additional information: https://www.karger.com/JIN

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.